- 专利标题: Nanogel-mediated drug delivery
-
申请号: US16201505申请日: 2018-11-27
-
公开(公告)号: US10729659B2公开(公告)日: 2020-08-04
- 发明人: Vinod Labhasetwar , Sivakumar Vijayaraghavalu
- 申请人: The Cleveland Clinic Foundation
- 申请人地址: US OH Cleveland
- 专利权人: THE CLEVELAND CLINIC FOUNDATION
- 当前专利权人: THE CLEVELAND CLINIC FOUNDATION
- 当前专利权人地址: US OH Cleveland
- 代理机构: Hamilton, Brook, Smith & Reynolds, P.C.
- 主分类号: A61K9/51
- IPC分类号: A61K9/51 ; A61K45/06 ; A61K31/706 ; A61K31/704 ; A61K31/7068
摘要:
Provided herein are methods of inhibiting proliferation of one or more tumor cells comprising contacting the one or more tumor cells with a composition comprising one or more epigenetic drugs that inhibit one or more epigenetic mechanisms of the tumor cells, wherein the one or more epigenetic drugs are encapsulated in a nanogel. The invention is also directed to methods of treating a tumor, metastasis of a tumor or a combination thereof in an individual in need thereof. The invention is also directed to a method of sequentially delivering one or more epigenetic drugs that alter one or more epigenetic mechanisms of a tumor cell and one or more chemotherapeutic drugs to an individual that has a tumor. Compositions which comprise one or more epigenetic drugs that alter one or more epigenetic mechanisms of a tumor cell, wherein the one or more epigenetic drugs are encapsulated in a nanogel.
公开/授权文献
- US20190091161A1 Nanogel-Mediated Drug Delivery 公开/授权日:2019-03-28
信息查询